Pages that link to "Q43545011"

The following pages link to Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors (Q43545011):

Displaying 22 items.

• Avian influenza virus infections in humans (Q30231417) (← links)
• New millennium antivirals against pandemic and epidemic influenza: the neuraminidase inhibitors. (Q30332341) (← links)
• Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States (Q30400342) (← links)
• Peramivir for the treatment of influenza (Q30413154) (← links)
• Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors (Q30450742) (← links)
• Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season (Q34614814) (← links)
• Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer (Q34759825) (← links)
• Efficacy of single intravenous injection of peramivir against influenza B virus infection in ferrets and cynomolgus macaques (Q35364037) (← links)
• Economic evaluations of neuraminidase inhibitors to control influenza (Q36020202) (← links)
• Therapeutic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H275Y neuraminidase mutation (Q36171626) (← links)
• Treatment of respiratory virus infections (Q36411968) (← links)
• The threat of avian influenza A (H5N1). Part III: Antiviral therapy. (Q36790658) (← links)
• Prophylactic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H274Y neuraminidase mutation (Q39713091) (← links)
• Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B. (Q40277368) (← links)
• A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons. (Q40474661) (← links)
• Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season (Q40511008) (← links)
• Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients (Q42200492) (← links)
• A cluster of patients infected with I221V influenza b virus variants with reduced oseltamivir susceptibility--North Carolina and South Carolina, 2010-2011. (Q42282531) (← links)
• Impact of calcium on N1 influenza neuraminidase dynamics and binding free energy (Q42734341) (← links)
• Evaluation of in vitro antiviral activity in methanol extracts against influenza virus type A from Korean medicinal plants (Q43210859) (← links)
• Computational study on new natural polycyclic compounds of H1N1 influenza virus neuraminidase (Q45360162) (← links)
• Prediction of zanamivir efficiency over the possible 2009 influenza A (H1N1) mutants by multiple molecular dynamics simulations and free energy calculations (Q83072123) (← links)